glp-1 agonists quizlet Incretin hormones (L5) Flashcards Perioperative management of patients taking
Description
Chuang MH, Chen JY, Wang HY, Jiang ZH, Wu VC
The foundation's Canadian survey found that 51 percent of employers now cover GLP-1 drugs for diabetes alone, down from 56 percent in 2025 and 66 percent in 2024
35 Clinical data are limited regarding the use of DPP-4 inhibitors to prevent retinopathy
& Skibicka, K
Research published in the last week revealed that for the first time in more than a decade, obesity rates among US adults fell slightly last year, decreasing from 46% in 2022 to 45.6% in 2023
